Quanterix Corporation (QTRX) Hit All-Time Low at $13.95

June 29, 2018 - By Michael Day

On Jun, 29, all time low was touched by Quanterix Corporation (NASDAQ:QTRX). Today’s share price was $13.95. It’s 4.00 % below our $13.39. Barchart.com reported this technical pattern. Quanterix Corporation (NASDAQ:QTRX) has $306.34 million MC. At $13.39 stock target, the company valuation changes by $12.25 million less.

The stock decreased 0.92% or $0.13 during the last trading session, hitting $13.95.Currently Quanterix Corporation is after 0.00% change in last June 29, 2017. QTRX has also 46,443 shares volume. QTRX underperformed the S&P500 by 12.57%.

Quanterix Corporation (NASDAQ:QTRX) is anticipated to report earnings on August, 21., as reported by Faxor. Wall Street now sees -15.15 % EPS growth despite Quanterix Corporation last quarter’s EPS of $-0.33.

For more Quanterix Corporation (NASDAQ:QTRX) news posted recently go to: Businesswire.com, Benzinga.com, Seekingalpha.com, Benzinga.com or Businesswire.com. The titles are as follows: “EY Announces Kevin Hrusovsky, President, Chairman and Chief Executive Officer of Quanterix and Founder of …” posted on June 13, 2018, “The Week Ahead: Apple’s Developer Conference In The Spotlight, ASCO Meeting Could Move Biotechs” on June 04, 2018, “Stocks To Watch: Eyes On Apple’s WWDC, SCOTUS And DC” with a publish date: June 02, 2018, “45 Biggest Movers From Yesterday” and the last “Hercules Capital on Pace to Potentially Exceed $1.0 Billion in Total New Debt and Equity Commitments in 2018” with publication date: June 11, 2018.

Quanterix Corporation, a life sciences company, develops and markets ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and Asia Pacific.The company has $306.34 million market cap. It develops Simoa HD-1 Analyzer, a sensitive protein detection platform, which analyzes approximately six biomarkers per test; and SR-X system that supports the detection capability of approximately six biomarkers per test.Last it reported negative earnings. The company's products also comprise kits, such as beads, capture and detector reagents, enzyme reagents, and enzyme substrates to run tests; and consumables, such as proprietary Simoa disks, cuvettes, and disposable tips.

Quanterix Corporation (NASDAQ:QTRX) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: